Awareness of Genetic Polymorphism in Drug Metabolizing Enzymes and Transporters May Promote Personalized Type 2 Diabetes Management [Response to Letter]

David M Williams1 Department of Diabetes and Endocrinology, Morriston Hospital, Swansea Bay University Health Board, Swansea, SA6 8NL, UKCorrespondence[email protected]

https://orcid.org/0000-0001-9206-5837

Jeffrey W Stephens1 Department of Diabetes and Endocrinology, Morriston Hospital, Swansea Bay University Health Board, Swansea, SA6 8NL, UK;2 Diabetes Research Group, Swansea University Medical School, Swansea University, Swansea, SA2 8PP, UK

https://orcid.org/0000-0003-2228-086X

References

Williams DM, Jones H, Stephens JW. Personalized type 2 diabetes management: an update on recent advances and recommendations. Diabetes Metab Syndr Obes. 2022;15:281–295. doi:10.2147/DMSO.S331654
PubMedGoogle Scholar
Pearson ER. Diabetes: is there a future for pharmacogenomics guided treatment? Clin Pharmacol Ther. 2019;106:329–337. doi:10.1002/cpt.1484
PubMed Web of Science ®Google Scholar
Zeng Z, Huang SY, Sun T. Pharmacogenomic studies of current antidiabetic agents and potential new drug targets for precision medicine of diabetes. Diabetes Ther. 2020;11:2521–2538. doi:10.1007/s13300-020-00922-x
PubMed Web of Science ®Google Scholar
Zimdahl H, Ittrich C, Graefe-Mody U, et al. Influence of TCF7L2 gene variants on the therapeutic response to the dipeptidylpeptidase-4 inhibitor linagliptin. Diabetologia. 2014;57:1869–1875. doi:10.1007/s00125-014-3276-y
PubMed Web of Science ®Google Scholar
Daniels MA, Kan C, Willmes DM, et al. Pharmacogenomics in type 2 diabetes: oral antidiabetic drugs. Pharmacogenomics J. 2016;16:399–410. doi:10.1038/tpj.2016.54
PubMed Web of Science ®Google Scholar

Awareness of Genetic Polymorphism in Drug Metabolizing Enzymes and Transporters May Promote Personalized Type 2 Diabetes Management [Response to Letter]

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Awareness of Genetic Polymorphism in Drug Metabolizing Enzymes and Transporters May Promote Personalized Type 2 Diabetes Management [Response to Letter]

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date